{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T18:37:55Z","timestamp":1774982275965,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.clinthera.2011.11.020","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T08:43:56Z","timestamp":1323852236000},"page":"B40-B48","source":"Crossref","is-referenced-by-count":21,"title":["Clinical Relevance of Treatments for Acute Bipolar Disorder: Balancing Therapeutic and Adverse Effects"],"prefix":"10.1016","volume":"33","author":[{"given":"Shefali","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence A.","family":"Ketter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.11.020_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib2","series-title":"Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression","author":"Goodwin","year":"2007"},{"key":"10.1016\/j.clinthera.2011.11.020_bib3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2011.11.020_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2011.11.020_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2010.11.009","article-title":"Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania\u2014a systematic review and meta-analysis","volume":"134","author":"Tarr","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clinthera.2011.11.020_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)","volume":"26","author":"Thase","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.11.020_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4088\/JCP.08m04942gre","article-title":"A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)","volume":"71","author":"McElroy","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2009.10.007","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression","volume":"121","author":"Suppes","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clinthera.2011.11.020_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4088\/JCP.08m04995gre","article-title":"A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I)","volume":"71","author":"Young","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0447.2010.01645.x","article-title":"Treatments for bipolar disorder: can number needed to treat\/harm help inform clinical decisions?","volume":"123","author":"Ketter","year":"2011","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clinthera.2011.11.020_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","article-title":"Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials","volume":"8","author":"Kushner","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.clinthera.2011.11.020_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies","volume":"28","author":"Thase","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.11.020_bib15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4088\/JCP.09m05934","article-title":"Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial","volume":"72","author":"Sachs","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1600-0447.2008.01194.x","article-title":"Compelling or irrelevant?","volume":"117","author":"Citrome","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clinthera.2011.11.020_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/157488609789006985","article-title":"Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications","volume":"4","author":"Citrome","year":"2009","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.clinthera.2011.11.020_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs lithium and placebo in the treatment of mania","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.11.020_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib20","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania","volume":"67","author":"Bowden","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Weisler","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4088\/JCP.v66n0308","article-title":"Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Weisler","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania","volume":"156","author":"Tohen","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study","volume":"57","author":"Tohen","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","article-title":"Risperidone in the treatment of acute mania: double-blind, placebo-controlled study","volume":"187","author":"Khanna","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","article-title":"Quetiapine or haloperidol as monotherapy for bipolar mania\u2014a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"15","author":"McIntyre","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.clinthera.2011.11.020_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","article-title":"Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial","volume":"25","author":"Potkin","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.11.020_bib30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.11.020_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","article-title":"A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.clinthera.2011.11.020_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2009.12.028","article-title":"Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial","volume":"122","author":"McIntyre","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clinthera.2011.11.020_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-5618.2010.00815.x","article-title":"A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder","volume":"12","author":"Vieta","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.clinthera.2011.11.020_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","article-title":"Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials","volume":"10","author":"Calabrese","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.clinthera.2011.11.020_bib37","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1176\/appi.ps.62.9.1032","article-title":"Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder","volume":"62","author":"Rascati","year":"2011","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.clinthera.2011.11.020_bib38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4088\/JCP.v69n0217","article-title":"A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence","volume":"69","author":"Gao","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib41","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4088\/JCP.09r05535gre","article-title":"Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics","volume":"72","author":"Gao","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.11.020_bib42","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1517\/14656566.2011.632368","article-title":"Olanzapine-fluoxetine combination for the treatment of bipolar depression","volume":"12","author":"Citrome","year":"2011","journal-title":"Expert Opin Pharmacother"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T20:22:18Z","timestamp":1686514938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811007715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0149291811007715"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.11.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}